{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:53:07Z","timestamp":1787683987929,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder characterized by clonal proliferation of neoplastic Langerhans cells (LCs). LC proliferation can also be seen in different reactive dermatosis. CyclinD1 is a downstream marker of mitogen-activated protein (MAP) kinase pathway, which is often activated in LCH. This study aimed to evaluate the role of cyclinD1 to differentiate reactive LC proliferation from LCH. All cases of cutaneous LCH diagnosed by biopsy in the past 3 years (n = 13) were immunostained with CD1a, p53, CD31, and cyclinD1. Seven cases each of discoid lupus erythematosus (DLE) and lichen planus (LP) were taken as control. Presence of p53, CD31, and cyclinD1-positive LCs (CD1a-positive) were compared in the dermis. In all LCH cases, dermal neoplastic LCs showed diffuse CD1a positivity and 12 cases (92.3%) showed variable (30%\u201370%) cyclinD1 expression. Weak p53 and CD31 expression were seen in 61.5% and 46.1% of LCH cases, respectively. In the control group, 5 cases of LP and 4 cases of DLE showed variable LC proliferation, highlighted by CD1a positivity. However, no case of reactive dermatosis showed cyclinD1 or p53 expression by the reactive LCs. Weak and patchy CD31 expression by the reactive LCs were found in 1 (25%) and 2 (40%) cases of DLE and LP, respectively. To conclude, cyclinD1 is frequently expressed in neoplastic LCs in LCH. It is an efficient marker to differentiate neoplastic from reactive LC proliferation, and can be used as a surrogate marker in LCH.<\/jats:p>","DOI":"10.1097\/dad.0000000000001250","type":"journal-article","created":{"date-parts":[[2018,8,19]],"date-time":"2018-08-19T23:26:24Z","timestamp":1534721184000},"page":"188-192","source":"Crossref","is-referenced-by-count":35,"title":["CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells"],"prefix":"10.1097","volume":"41","author":[{"given":"Debajyoti","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Histopathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikarn","family":"Vishwajeet","sequence":"additional","affiliation":[{"name":"Histopathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Nahar","family":"Saikia","sequence":"additional","affiliation":[{"name":"Histopathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishan","family":"Radotra","sequence":"additional","affiliation":[{"name":"Histopathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"De","sequence":"additional","affiliation":[{"name":"Dermatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0b013e31815b212b","article-title":"Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders","volume":"32","author":"Lau","year":"2008","journal-title":"Am J Surg Pathol."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10024-004-3027-z","article-title":"Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders","volume":"7","author":"Chikwava","year":"2004","journal-title":"Pediatr Dev Pathol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0714.1997.tb00454.x","article-title":"Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP)","volume":"26","author":"McCartan","year":"1997","journal-title":"J Oral Pathol Med."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.oooo.2011.12.008","article-title":"Increased number of Langerhans cells in oral lichen planus and oral lichenoid lesions","volume":"113","author":"Gueiros","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00043426-200212000-00010","article-title":"p53 expression in biopsies from children with Langerhans cell histiocytosis","volume":"24","author":"Bank","year":"2002","journal-title":"J Pediatr Hematol Oncol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/MPH.0b013e31828e51ae","article-title":"VEGF and p53 biomarkers in pediatric patients with Langerhans cell histiocytosis","volume":"35","author":"Mehrazma","year":"2013","journal-title":"J Pediatr Hematol Oncol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5858\/2003-127-0341-SHWMLA","article-title":"Sinus histiocytosis with massive lymphadenopathy and Langerhans cell histiocytosis express the cellular adhesion molecule CD31","volume":"127","author":"Slone","year":"2003","journal-title":"Arch Pathol Lab Med."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/DAD.0000000000000778","article-title":"p53 is a helpful marker in distinguishing Langerhans cell histiocytosis from Langerhans cell hyperplasia","volume":"39","author":"Grace","year":"2017","journal-title":"Am J Dermatopathol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2015.12.029","article-title":"BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases","volume":"52","author":"Alayed","year":"2016","journal-title":"Hum Pathol."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of Langerhans cell histiocytosis but not reactive Langerhans cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/00016350601137251","article-title":"Langerin-expressing and CD83-expressing cells in oral lichen planus lesions","volume":"65","author":"Gustafson","year":"2007","journal-title":"Acta Odontol Scand."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2005.08.024","article-title":"Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?","volume":"37","author":"Christie","year":"2006","journal-title":"Hum Pathol."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1309\/AJCPRHM8CZH5EMFD","article-title":"The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors","volume":"143","author":"Vanchinathan","year":"2015","journal-title":"Am J Clin Pathol."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00000478-200109000-00007","article-title":"CD31 expression in intratumoral macrophages: a potential diagnostic pitfall","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/hon.2293","article-title":"Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan","volume":"35","author":"Sasaki","year":"2017","journal-title":"Hematol Oncol."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","article-title":"Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis","volume":"128","author":"Chakraborty","year":"2016","journal-title":"Blood."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1183\/13993003.01677-2015","article-title":"Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis","volume":"47","author":"Mourah","year":"2016","journal-title":"Eur Respir J."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20161881","article-title":"RAF\/MEK\/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions","volume":"215","author":"Hogstad","year":"2018","journal-title":"J Exp Med."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/asheducation-2015.1.565","article-title":"Treatment of Langerhans cell histiocytosis: role of BRAF\/MAPK inhibition","volume":"2015","author":"Abla","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"R22-20230908","first-page":"122","article-title":"Langerhans cell histiocytosis: emerging insights and clinical implications","volume":"30","author":"Zinn","year":"2016","journal-title":"Oncology (Williston Park)."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201903000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:02:00Z","timestamp":1694149320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201903000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001250","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}